| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
 India |  United Kingdom | India | United Kingdom | India | United Kingdom | India | United Kingdom | India | United Kingdom | |
| Diabetes estimates (20-79 y) | ||||||||||
| People with diabetes, in 1,000s | 32,674.4 | 1,466.8 | 61,258.4 | 3,063.9 | 74,194.7 | 3,996.3 | 92,973.7 | 4,140.6 | 124,874.7 | 4,408.1 |
| Age-adjusted comparative prevalence of diabetes, % | - | - | 9.0 | 5.2 | 9.6 | 6.3 | 10.4 | 7.0 | 10.8 | 7.5 |
| People with undiagnosed diabetes, in 1,000s | - | - | - | - | 39,397.4 | 921.1 | - | - | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | - | - | 53.1 | 23.0 | - | - | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | ||||||||||
| People with IGT, in 1,000s | - | - | 20,467.5 | 4,119.3 | 40,143.8 | 2,967.6 | 50,045.4 | 3,019.4 | 65,557.3 | 3,202.4 |
| Age-adjusted comparative prevalence of IGT, % | - | - | 3.0 | 7.4 | 5.4 | 5.3 | 5.6 | 5.5 | 5.8 | 5.7 |
| Mortality attributable to diabetes (20-79 y) | ||||||||||
| Deaths attributable to diabetes | - | - | 983,203.0 | 25,052.0 | 647,831.0 | 140,775.0 | - | - | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | - | - | 2.8 | 1.7 | - | - | - | - |
| Type 1 diabetes estimates in children and adolescents | ||||||||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 18.1 | 2.1 | 0.0 | 0.3 | 19.2 | 2.7 | - | - | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | - | - | 24.0 | 3.5 | - | - | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 66.9 | 12.5 | - | - | 124.6 | 17.2 | - | - | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | - | - | 229.4 | 31.6 | - | - | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||||||||
| Live births affected by HIP | - | - | - | - | 6,182,373.9 | 183,322.8 | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - | 29.3 | 20.6 | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - | 220,541.9 | 2,539.0 | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - | 194,791.2 | 8,381.3 | - | - | - | - |
| Diabetes-related health expenditure | ||||||||||
| Total diabetes-related health expenditure, USD million | - | - | - | - | 8,485.8 | 23,415.4 | 10,305.5 | 23,815.4 | 12,834.3 | 23,949.2 |
| Total diabetes-related health expenditure, ID million | - | - | - | - | 32,054.9 | 25,065.7 | 38,928.6 | 25,493.9 | 48,481.1 | 25,637.1 |
| Diabetes-related health expenditure per person, USD | - | - | 68.0 | 4,267.0 | 114.4 | 5,859.3 | 138.9 | 5,959.4 | 173.0 | 5,992.9 |
| Diabetes-related health expenditure per person, ID | - | - | - | - | 432.0 | 6,272.2 | 524.7 | 6,379.4 | 653.4 | 6,415.2 |
| Demographics | ||||||||||
| Total adult population (20-79 y), in 1,000s | 567,714.0 | 41,638.0 | 737,003.3 | 44,813.1 | 893,910.0 | 48,928.0 | 1,022,119.2 | 49,998.8 | 1,154,012.2 | 51,605.3 |
| Population of children (0-14 y), in 1,000s | 361,182.0 | 11,513.0 | - | - | 359,208.6 | 12,020.4 | - | - | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | - | - | 485,464.9 | 15,746.2 | - | - | - | - |
| Impaired fasting glucose (IFG) estimates (20-79 y) | ||||||||||
| People with IFG, in 1,000s | - | - | - | - | 75,123.9 | 2,808.8 | 85,065.3 | 2,936.8 | 95,598.7 | 3,081.2 |
| Age-adjusted comparative prevalence of IFG, % | - | - | - | - | 7.8 | 4.9 | 8.2 | 5.3 | 8.3 | 5.5 |
| Complications of diabetes | India | United Kingdom | ||||||||
| Microvascular | ||||||||||
| Nephropathy | 5.9% | - | ||||||||
| Retinopathy | 0.8% | - | ||||||||
| Neuropathy | 10.6% | - | ||||||||
| Macrovascular | ||||||||||
| Coronary artery disease | 2.5% | - | ||||||||
| Cerebrovascular disease | 0.3% | - | ||||||||
| Peripheral artery disease | 0.0% | - | ||||||||
| Heart failure | 0.2% | - | ||||||||